Mumbai, India

Sadashiv M Mandrekar

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sadashiv M Mandrekar. Retrieved from https://idiyas.com/inventor/sadashiv-m-mandrekar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sadashiv M Mandrekar: Innovator in Immunosuppressive Compounds

Introduction

Sadashiv M Mandrekar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of immunosuppressive compounds. His work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Mandrekar holds a patent for an immunosuppressive chromone alkaloid. The patent describes a compound with specific properties that can be isolated from plants belonging to the Meliaceae family. This compound is particularly noteworthy for its immunosuppressive properties, making it a candidate for use as a medicament.

Career Highlights

He is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical sector. His role at the company has allowed him to engage in innovative research and development, contributing to advancements in medicinal compounds.

Collaborations

Mandrekar has collaborated with notable colleagues, including Roland Kurrle and Sujata Vasudev Bhat. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality of research and development in their projects.

Conclusion

Sadashiv M Mandrekar's contributions to the field of immunosuppressive compounds highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…